Email This Content
Send an email to a colleague about this document. Non-subscribers may purchase the article.© Copyright 2010 WINDHOVER INFORMATION INC., All Rights Reserved
Windhover Information Inc. - Health Care Business Intelligence
Delivering essential analysis and insights to top health care executives, investment professionals, and industry consultants
By Michael Lachman, Medtech Insight 1/1/2010
Medtech Insight -- In August 2009, vertebral compression fracture treatment was dealt an unexpected blow when The New England Journal of Medicine published two articles that detailed prospective randomized controlled trials in which vertebroplasty did not result in a statistically significant clinical benefit over a sham procedure. The spinal community responded quickly to these articles, pointing out shortcomings of the two trials.
For $85, purchase this 2140-word article as a PDF, and receive immediate delivery via email. View a complete sample article.
Questions? Call Toll Free (800) 332-2181 or (908) 547-2159.
100% Satisfaction Guarantee
If you are already a subscriber, please log in for complete access. 
Questions? Call Toll Free (800) 332-2181 or (908) 547-2159.
